On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Stocks To Buy Now


Developing Cannabinoid Opportunities Provide HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF) Favorable Outlook for Hemp Operations

  • HTC Extraction Systems has developed more than a decade’s experience of building revenues from chemical distillation, and is now using that skillset to enter the increasingly popular arena of cannabinoid consumerism
  • The company is finalizing the equipping of facilities in western Canada and California as its cannabinoid extract tolling operations grow
  • HTC’s most recent financial report celebrated rising revenues, with a year-over-year increase of nearly 200 percent

In the United States, this year’s national elections promise to keep federal cannabis policy in the spotlight as the large majority of Democratic challengers are fine tuning their pro-pot policies and surveys are showing the majority of Americans prefer more sweeping legalization than federal agencies have been willing to pursue under presidential administrations thus far (http://ibn.fm/kvgTU).

Regardless of the elections’ outcomes, it’s clear that cannabinoid producers and cannabinoid products have been gaining ground in terms of public acceptance and legal permissiveness in most areas of the country. Federal legalization in Canada and Mexico is developing a geopolitical bloc for North American cannabinoid advocates.

HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF) has turned its proprietary purification technologies to the task of producing profits within the realm of cannabinoids’ ballooning popularity. The Saskatchewan, Canada-based company is completing new facilities on western Canada’s vast farmlands for harvesting ethanol and ethanol-based extracts from hemp for the cannabidiol (CBD) food and pharmaceutical markets, while extending its reach into the United States through a November purchase agreement which granted the company ownership of Kase Farma Inc., a company authorized to work with hemp cultivation, extraction, refining, formulation and distribution in California (http://ibn.fm/HvRVX).

HTC’s third-quarter financial statement noted revenues had grown by nearly 200 percent in year-over-year quarterly returns, from $1.3 million at the close of September 2018 to $3.3 million by September of this year (http://ibn.fm/vYOVo). Year-end financials are pending.

The company is pursuing a “BOOM” business model in which HTC either obtains participating equity ownership in a production chain partner or uses tolling agreements to keep a percentage of the CBD extract it distills for future sales and offtake agreements, including sales to the cannabinoid pharmaceutical market – building, owning, operating and maintaining its own resources.

HTC has developed and improved on its proprietary systems for biomass, gas and liquid extraction over the course of 14 years. Its trademarked Delta Reclaiming System technology is founded in distillation processes that remove ethanol and ethanol-based solvents used in the extraction process, and the company expects to distribute its CBD through its partnership with Purely Canada Foods.

Purely Canada Foods has been a standard bearer for national pride, providing quality-assured branded products to numerous countries in the North American, Asian, European and African markets (http://ibn.fm/r9Mkq). HTC believes its patented Delta Purification System is now the best available environmental reclaiming technology for the clean energy and biomass extraction industries.

For more information, visit the company’s website at www.HTCExtraction.com

NOTE TO INVESTORS: The latest news and updates relating to HTC are available in the company’s newsroom at http://ibn.fm/HTC

From Our Blog

Brain Scientific Inc. (BRSF) Releases 2020 Financial, Business Results

May 11, 2021

BRSF made strides on operations front to improve lead times, quality control Company experienced revenue growth, increase in assets and R&D Brain Scientific has identified that only 30% of U.S. hospitals have equipment for routine EEGs due to cost and space constraints Brain Scientific (OTCQB: BRSF), a commercial-stage, health-care company, announced it has filed its annual […]

Rotate your device 90° to view site.